CLINICAL ROLE -
Twitter Proves Useful as a Platform to Discuss Adverse Events
Less serious adverse events remain a concern for patients treated for chronic diseases.
Read More
UV Light Could Fight the Spread of Influenza
Ultraviolet C light could be safely harnessed to kill influenza microbes.
Trending News Today: Idaho Violates ACA Law with 'Skinny' Health Plans
Top news of the day from across the health care landscape.
Trending News Today: Health Care Spending to Reach $5.7 Trillion in 2026
What are the Benefits for Pharmacists to Pursue HIV Credentialing?
Many pharmacists are turning to credentialing as a way to distinguish themselves professionally.
Migraines May Be Key Risk Factor for Cardiovascular Diseases
In addition to myocardial infarction and stroke, migraines may also be linked to an increased risk for venous thromboembolism and atrial fibrillation.
Post-Lung Surgery Opioid Prescriptions May Lead to Dependency
Surgeons may play an integral role in preventing opioid dependency in surgery patients.
New Prostate Cancer Drug Gets FDA OK
First Non-Metastatic, Castration-Resistant Prostate Cancer Drug Gets FDA Nod
Apalutamide (Erleada) was approved based on metastasis-free survival, which is a new clinical endpoint.
Kymriah Treatment Pulls Young Leukemia Patient from the Darkness
Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.
Pursuing Credentialing in HIV: Why? Why Not?
As the job market for pharmacists becomes more competitive, many pharmacists are turning to credentialing as a way to distinguish themselves professionally.
Migraine May Be Linked to More Cardiovascular Diseases, Study Says
Migraines may be an important risk factor for several cardiovascular diseases, apart from stroke and heart attacks.
Technological Advancements Clear Path to HIV Vaccine
Current production methods make it difficult to mass produce an effective HIV vaccine.
Experimental Drug Fails in Alzheimer's Disease Trial
An investigational PDE9A inhibitor did not show efficacy in patients with Alzheimer’s disease.
Drug Can Starve Cancer Stem Cells
An existing drug can prevent cancerous stem cells from reproducing, without the toxic adverse effects of chemotherapy.
New York Governor Tackles Flu Epidemic Through Increased Pharmacist Involvement
An executive order allows New York pharmacists to administer the influenza vaccine to children.
New Cases of Influenza Continue to Break Records
Nearly all states are experiencing a high burden from the flu, according to the CDC.
Trending News Today: Republicans Discuss Repealing ACA Employer Mandate
Trending News Today: Obesity Linked to Higher Metastatic Melanoma Survival in Men
Female Hormones Shown to Reduce HIV Replication
Exposure to high levels of estrogen and progesterone may help curb proinflammatory cytokine and chemokine expression associated with HIV-1.
Love Educating Patients During American Heart Month
February is American Heart Month.
FDA OKs Combo Treatment for Cystic Fibrosis Caused by Certain Mutations
FDA officials have approved tezacaftor/ivacaftor and ivacaftor (Symdeko, Vertex Pharmaceuticals) for the treatment of cystic fibrosis (CF) in individuals aged 12 years and older.
Increases in Cost, Utilization Drive Specialty Drug Spending Growth
Annual Express Scripts drug trend report shows overall reduction in per person prescription drug spending.
Blood Test Could Provide Clues About Immunotherapy Efficacy
The ratio of immune cells in the blood can determine whether a patient with cancer will respond to immunotherapy.
Balance Improves with Exercise in Patients with Multiple Sclerosis
Balance and eye movement exercise improved quality of life for patients with multiple sclerosis.
Threat of Drug-Resistant E. Coli Increases with Pediatric Antibiotic Prescriptions
Antibiotics may become ineffective treating E. Coli if antibiotic resistance continues to increase among children.
Trending News Today: Proposed Budget May Not Fully Address Cause of High Drug Costs
Trending News Today: Federal Funding Contributes to Large Number of Drug Approvals
FDA Approves Generic Drug for Relapsing Multiple Sclerosis
Officials with the FDA have approved Novartis' glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS).
Generic Drug Approved for Relapsing Multiple Sclerosis
Generic glatiramer acetate injection is now available in a full range of dosing options for multiple sclerosis.